RxDoctor Payments Data

Thomas Wiley, MD

Clinical Cardiac Electrophysiology · Hickory, NCNPI 1144285123

Payments from drug & device makers

$3,663in general payments, 2019–2025

Across 204 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$393
  • Johnson & Johnson$335
  • Atricure, Inc.$330
  • E.r. Squibb & Sons, L.L.C.$315
  • Novartis$275
  • Pfizer$249
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,659100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,663 in reported general payments places this provider in the 10th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

See all clinical cardiac electrophysiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$165,091
Medicare patients
823
Services billed
3,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban552$543,961
XareltoRivaroxaban74$71,807
EntrestoSacubitril/Valsartan55$54,505
Flecainide Acetate188$5,534
Dofetilide27$5,414
Diltiazem 24hr Er (Cd)Diltiazem Hcl180$4,990
Metoprolol Succinate365$3,933
SotalolSotalol Hcl84$1,329
Digoxin59$912
Amiodarone Hcl67$665
Atorvastatin Calcium50$631
Carvedilol65$535
Cartia XtDiltiazem Hcl13$463
Nadolol16$446
Eplerenone15$406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$249$543,961552 claims
Johnson & JohnsonXarelto$335$71,80774 claims
NovartisEntresto$275$54,50555 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

Other clinical cardiac electrophysiology in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →